ITI Pharma and Healthcare Fund Regular-Growth - Returns, Rating & Analysis | Ionic Wealth
ITI Pharma and Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.54% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic AI
Loading...
Fund Overview
Rating
1
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹230 Cr
Created on
1 Nov 2021
Fund Ranking
#14
/ 14 in Sectoral-Pharma
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
2.3%
1 Year
3.4%
3 Year (CAGR)
19.1%
All Time (CAGR)
11.4%
Category Return
6 Month
4.9%
1 Year
10.6%
3 Year (CAGR)
23.0%
All Time (CAGR)
-
Asset Allocation
Equity
98.3%
Other
1.7%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
6.25%
Astrazeneca Pharma India
0.69%
Aurobindo Pharma
4.36%
Linde India
1.37%
Caplin Point Laboratories
0.78%
Fund Information
Expense Ratio
2.38%
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Lock-In Period
No Lock-In
Managed By
Rohan Korde
Oct 2021 - Present
Tanay Gabhawala
Oct 2022 - Present
Rajesh Bhatia
June 2024 - Present
Dhimant Shah
Dec 2022 - Present
Nilay Dalal
May 2026 - Present
Animesh Singh
May 2026 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.82
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
16.77
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
-4.71
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.